1. Deininger K, Raacke JN, Yousefzadeh-Nowshahr E, Kropf-Sanchen C, Muehling B, Beer M, Glatting G, Beer AJ, Thaiss W. Combined morphologic-metabolic biomarkers from [18F]FDG-PET/CT stratify prognostic groups in low-risk NSCLC. Nuklearmedizin 2023.
  2. Gabiña PM, Gleisner KS, Cremonesi M, Stokke C, Flux G, Cicone F, Konijnenberg M, Aldridge M, Sandstrom M, Chiesa C, Paphiti M, Hippeläinen E, Uribe C, Solny P, Gnesin S, Bernhardt P, Chouin N, Costa PF, Glatting G, Verburg F, Gear J. Results from an EANM survey on time estimates and personnel responsible for main tasks in molecular radiotherapy dosimetry. Eur J Nucl Med Mol Imaging 2023; 50: 2595-604.
  3. Gierse M, Nagel L, Keim M, Lucas S, Speidel T, Lobmeyer T, Winter G, Josten F, Karaali S, Fellermann M, Scheuer J, Müller C, van Heijster F, Skinner J, Löffler J, Parker A, Handwerker J, Marshall A, Salhov A, El-Kassem B, Vassiliou C, Blanchard JW, Picazo-Frutos R, Eills J, Barth H, Jelezko F, Rasche V, Schilling F, Schwartz I, Knecht S. Parahydrogen-Polarized Fumarate for Preclinical in Vivo Metabolic Magnetic Resonance Imaging. J Am Chem Soc 2023
  4. Hardiansyah D, Riana A, Beer AJ, Glatting G. Single-time-point dosimetry using model selection and nonlinear mixed-effects modelling: a proof of concept. Ejnmmi Physics 2023; 10: 12.
  5. Hardiansyah D, Riana A, Beer AJ, Glatting G. Single-time-point estimation of absorbed doses in PRRT using a non-linear mixed-effects model. Zeitschrift für Medizinische Physik 2022.
  6. Hardiansyah D, Riana A, Eiber M, Beer AJ, Glatting G. Population-based model selection for an accurate estimation of time-integrated activity using non-linear mixed-effects modelling. Z Med Phys 2023.
  7. Harms M, Fabech Hansson R, Gilg A, Almeida-Hernández Y, Löffler J, Rodríguez-Alfonso A, Habib MMW, Albers D, Ahmed NS, Abadi AH, Winter G, Rasche V, Beer AJ, Weidinger G, Preising N, Ständker L, Wiese S, Sanchez-Garcia E, Zelikin AN, Münch J. Development of N-Terminally Modified Variants of the CXCR4-Antagonistic Peptide EPI-X4 for Enhanced Plasma Stability. J Med Chem 2023
  8. Hilbrig C, Löffler J, Fischer G, Scheidhauer E, Solbach C, Huber-Lang M, Beer AJ, Rasche V, Winter G. Evaluation of the EPR Effect in the CAM-Model by Molecular Imaging with MRI and PET Using 89Zr-Labeled HSA. Cancers 2023; 15: 1126
  9. Muller D, Herrmann H, Schultz MK, Solbach C, Ettrich T, Prasad V. Pb-203-VMT-alpha-NET Scintigraphy of a Patient With Neuroendocrine Tumor. Clin Nucl Med 2023; 48: 54-5.
  10. Nasir Z, Probst L, Schneider F, Clausen S, Burgy D, Glatting G, Nwankwo O. Organ absorbed doses in the IORT treatment of breast cancer with the INTRABEAM device: a Monte-Carlo study. Biomedical Physics & Engineering Express 2023; 9: 11
  11. Pouget JP, Konijnenberg M, Eberlein U, Glatting G, Gabina PM, Herrmann K, Holm S, Strigari L, van Leeuwen FWB, Lassmann M. An EANM position paper on advancing radiobiology for shaping the future of nuclear medicine. Eur J Nucl Med Mol Imaging 2023; 50(2): 242-246
  12. Rahbar K, Essler M, Pabst KM, Eiber M, la Fougère CP, Prasad V, Rassek P, Hasa E, Dittmann H, Bundschuh RA, Fendler WP, Kurtinecz M, Schmall A, Verholen F, Sartor AO. Safety and Survival Outcomes of Lutetium-177-Prostate-Specific Membrane Antigen Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer with prior Radium-223 treatment: The RALU Study. J Nucl Med 2022.
  13. Rieh L, Mulaw M, Kneer K, Beer M, Beer A, Bart TF, Benes V, Schulte J, Fischer M, Debatin KM, Beltinger C. Targeted parallel DNA sequencing detects circulating tumor-associated variants of the mitochondrial and nuclear genomes in patients with neuroblastoma. Cancer Reports 2023; 6: 12.
  14. Schulze R, Solbach C, Patt M, Breitkreutz F. Die „sachkundige Person“ in der Radiopharmazie – Herstellungserlaubnis oder nicht? Nuklearmedizin 2023.
  15. Thaiss W, Zengerling F, Friedrich J, Hechler V, Grunert M, Bolenz C, Wiegel T, Beer AJ, Prasad V. Personalized [177Lu]Lutetium-PSMA Therapy for Patients with Pre-Treated Castration-Resistant Prostate Cancer: A Single Institution Experience from a Comprehensive Cancer Centre. Cancers 2023; 15: 3216.
  16. Wanek T, Mairinger S, Raabe M, Alam MNA, Filip T, Stanek J, Winter G, Xu L, Laube C, Weil T, Rasche V, Kuntner C. Synthesis, radiolabeling, and preclinical in vivo evaluation of 68Ga-radiolabelled nanodiamonds. Nuclear Medicine and Biology 2023; 116-117: 108310
  17. Weikert T, Jaeger PF, Yang S, Baumgartner M, Breit HC, Winkel DJ, Sommer G, Stieltjes B, Thaiss W, Bremerich J, Maier-Hein KH, Sauter AW. Automated lung cancer assessment on 18F-PET/CT using Retina U-Net and anatomical region segmentation. European Radiology 2023: 10.
  18. Winter G, Hamp-Goldstein C, Fischer G, Kletting P, Glatting G, Solbach C, Herrmann H, Sala E, Feuring M, Döhner H, Beer AJ, Bunjes D, Prasad V. Optimization of Radiolabeling of a [90Y]Y-Anti-CD66-Antibody for Radioimmunotherapy before Allogeneic Hematopoietic Cell Transplantation. Cancers 2023; 15: 3660.
  19. Zaid NRR, Kletting P, Beer AJ, Rozgaja Stallons TA, Torgue JJ, Glatting G. Mathematical modeling of in vivo alpha particle generators and chelator stability. Cancer Biother Radiopharm 2022; epub 21.01.2021